Pfizer and Anumana Ink Multi-Year AI Electrocardiogram Algorithm Deal

Related Articles
Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence
Biospace: Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of artificial…July 12, 2022
Mayo Clinic Launches Two Companies To Support New Remote Monitoring Initiative
Medtech Insight: The Minnesota-based health care system announced the formation of Anumana Inc. to commercialize artificial intelligence-enabled algorithms and Lucem Health to curate data collected from remote monitoring devices.April 13, 2021
AI researchers at Mayo Clinic use the Apple Watch to detect silent, weakening heart disease
FIERCE Biotech: Using simplified ECG data taken from an Apple Watch, researchers at the Mayo Clinic were able to use an artificial intelligence algorithm to spot people whose hearts may…May 02, 2022
Anumana Joins the American College of Cardiology to Advance AI-Powered Solutions for Detecting Heart Failure
Anumana’s joins ACC to advance AI solutions for detecting heart failureDecember 12, 2024


